Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04772482 · ClinicalTrials.gov registry record
Study on Hypoallergenic Hair Dye
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 8
- Enrollment target
NCT04772482: Completed study, sponsored by University of Minnesota.
NCT04772482 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04772482 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
Study Summary
Permanent hair dyes are commonly used in over the counter direct to consumer products and within hair salons. Allergy, also known as contact dermatitis, to hair dye is a well known phenomenon. Herein, we seek to decrease the risks of allergy to hair dyes by testing a novel version of p-phenylenediamine (PPD) with less allergy potential.
Primary Outcome
The primary endpoint of the study is the percent of participants with a known PPD allergy who experience an allergic reaction to the study compounds PPD6 or PPD7.
Interventions
- DIAGNOSTIC_TEST Sensitivity Patch Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2021-04-01 |
| Est. Completion | 2022-05-13 |
What the finished NCT04772482 record still lists
NCT04772482 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Sensitivity Patch Testing is the first listed.
NCT04772482 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04772482 about?
NCT04772482 is a clinical study titled "Study on Hypoallergenic Hair Dye". Permanent hair dyes are commonly used in over the counter direct to consumer products and within hair salons. Allergy, also known as contact dermatitis, to hair dye is a well known phenomenon. Herein, we seek to decrease the risks of allergy to hair dyes by testing a novel version of p-phenylenediam...
What is the current status of trial NCT04772482?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2021-04-01. Estimated completion is 2022-05-13.
What interventions are being tested in trial NCT04772482?
The interventions under investigation include: Sensitivity Patch Testing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04772482?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI